ION-682884

· Ionis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ION-682884, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: ION-682884 in Patients With TTR Amyloid Cardiomyopathy [Phase 2]